Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Logothetis

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Oncology (Williston Park, N.Y.)|July 11, 2002
Docetaxel in the management of advanced or metastatic urothelial tract cancerChristopher Logothetis, Randall Millikan
International Journal of Cancer|October 23, 2008
Targeting Src signaling in metastatic bone diseaseJohn Araujo, Christopher Logothetis
Cancer Treatment Reviews|March 16, 2010
Dasatinib: a potent SRC inhibitor in clinical development for the treatment of solid tumorsJohn Araujo, Christopher Logothetis
Science Translational Medicine|May 4, 2018
ER stress in prostate cancer: A therapeutically exploitable vulnerability?Christopher Logothetis, Ana Aparicio, Timothy C Thompson
BJU International|March 9, 2011
Current and emerging treatment modalities for metastatic castration-resistant prostate cancerSergio Bracarda, Christopher Logothetis, Cora N Sternberg, et al.
Cancer Metastasis Reviews|January 31, 2018
Current perspectives on bone metastases in castrate-resistant prostate cancerChristopher Logothetis, Michael J Morris, Robert Den, et al.
BMC Evolutionary Biology|March 18, 2014
Genes with a large intronic burden show greater evolutionary conservation on the protein levelOlga Gorlova, Alexey Fedorov, Christopher Logothetis, et al.
Bioinformatics (Oxford, England)|March 26, 2026
CpGene: A Web Application for Epigenetic Signature Identification from DNA Methylation ArraysKonstantinos Lazaros, Souzana Logotheti, Christopher Logothetis, et al.
Molecular Cancer Therapeutics|October 14, 2003
Differential effects of the proteasome inhibitor bortezomib on apoptosis and angiogenesis in human prostate tumor xenograftsSimon Williams, Curtis Pettaway, Rendu Song, et al.
The Journal of Urology|March 12, 2003
Regulation of Bcl-2 expression by dihydrotestosterone in hormone sensitive LNCaP-FGC prostate cancer cellsElizabeth M Bruckheimer, Kevin Spurgers, Nancy L Weigel, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Oncology (Williston Park, N.Y.)|July 11, 2002
Docetaxel in the management of advanced or metastatic urothelial tract cancerChristopher Logothetis, Randall Millikan
International Journal of Cancer|October 23, 2008
Targeting Src signaling in metastatic bone diseaseJohn Araujo, Christopher Logothetis
Cancer Treatment Reviews|March 16, 2010
Dasatinib: a potent SRC inhibitor in clinical development for the treatment of solid tumorsJohn Araujo, Christopher Logothetis
Science Translational Medicine|May 4, 2018
ER stress in prostate cancer: A therapeutically exploitable vulnerability?Christopher Logothetis, Ana Aparicio, Timothy C Thompson
BJU International|March 9, 2011
Current and emerging treatment modalities for metastatic castration-resistant prostate cancerSergio Bracarda, Christopher Logothetis, Cora N Sternberg, et al.
Cancer Metastasis Reviews|January 31, 2018
Current perspectives on bone metastases in castrate-resistant prostate cancerChristopher Logothetis, Michael J Morris, Robert Den, et al.
BMC Evolutionary Biology|March 18, 2014
Genes with a large intronic burden show greater evolutionary conservation on the protein levelOlga Gorlova, Alexey Fedorov, Christopher Logothetis, et al.
Bioinformatics (Oxford, England)|March 26, 2026
CpGene: A Web Application for Epigenetic Signature Identification from DNA Methylation ArraysKonstantinos Lazaros, Souzana Logotheti, Christopher Logothetis, et al.
Molecular Cancer Therapeutics|October 14, 2003
Differential effects of the proteasome inhibitor bortezomib on apoptosis and angiogenesis in human prostate tumor xenograftsSimon Williams, Curtis Pettaway, Rendu Song, et al.
The Journal of Urology|March 12, 2003
Regulation of Bcl-2 expression by dihydrotestosterone in hormone sensitive LNCaP-FGC prostate cancer cellsElizabeth M Bruckheimer, Kevin Spurgers, Nancy L Weigel, et al.
Pageof 9